speaker-icon

Latest Posts

Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences

28

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More
Partex-Group-presents-results-from-a-pilot-project-with-AIO

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Archives: News

5-Predictions-for-AI-in-2019

5 predictions for AI in 2019

While several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can the industry expect next year? Artificial intelligence (AI) made waves in the pharmaceutical industry last year​, with several large-scale deals, partnerships, and announcements, as researchers predict a revolution ​in drug discovery and preclinical development. In …

5 predictions for AI in 2019 Read More »

cio-review

Innoplexus Brings Blockchain to Pharma

Global AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research and discovery. This new platform, an update to Innoplexus’ flagship product iPlexus is the first of its kind and will enable researchers to upload and license unpublished data on the blockchain to facilitate collaboration, reduce …

Innoplexus Brings Blockchain to Pharma Read More »

handelsblatt

Founder fights cancer with artificial intelligence

Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to develop drugs more quickly. Frankfurt. It was a life-changing experience for Gunjan Bhardwaj to have a dear friend diagnosed with cancer years ago. In a desperate attempt to help, Bhardwaj, an Indian-born businessman, scavenged the …

Founder fights cancer with artificial intelligence Read More »

gunjan-bilanz

Google for Pharma

Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered by artificial intelligence and machine learning.The goal: Innoplexus wants to become the European champion for AI. The chances: excellent. At 35, Gunjan Bhardwaj was an aspiring management consultant at Ernst & Young. The atmosphere …

Google for Pharma Read More »

reflex-verlag

We want to democratize data

Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus software has crawled over 300 terabytes of relevant clinical and medical data and put them in a logical context, being constantly updated and delivered to the workstations of customers in …

We want to democratize data Read More »